Abstract:Guofei Feng, Pan Zhuge, Yaping Zou, Zhifeng Zhang, Jiandong Guo, Junxiang Ma Department of ENT, Jinhua Central Hospital, Jinhua, Zhejiang, 321000, People's Republic of China Correspondence: Guofei Feng, Department of ENT, Jinhua Central Hospital, No. 365, East Renmin Road, Jinhua, Zhejiang, 321000, People's Republic of China, Tel/Fax +86 579 82552620, Email Objective: To investigate the correlation between the levels of serum lipopolysaccharide (LPS), nuclear factor erythroid 2-related factor 2 (Nrf2), haem oxygenase 1 (HO-1) and cognitive impairment in patients with obstructive sleep apnoea (OSA). Methods: Serum LPS, Nrf2, HO-1 levels and cognitive impairment were measured using the Montreal Cognitive Assessment (MoCA) score in 56 patients in the "severe" group, 67 patients in the "mild-to-moderate" group and 100 healthy people in the "control" group. The differences in general conditions and serological indexes between the three groups were compared, the correlation between the MoCA scores and the serological indexes was explored and the independent predictors of the MoCA scores were analysed. Results: Serum LPS, Nrf2 and HO-1 levels were higher in the severe group than in the mild-to-moderate group and the control group ( p < 0.05). A total of 71 patients with OSA had combined cognitive impairment, accounting for 57.7%, and the MoCA scores were lower in the severe group than in the mild-to-moderate group and the control group ( p = 0.018). Serum LPS, Nrf2 and HO-1 levels were significantly higher in the severe group and mild-to-moderate group than in the control group ( p < 0.05) and were negatively correlated with the MoCA scores. Lipopolysaccharide ( p < 0.001) and HO-1 ( p = 0.002) could be considered independent predictors of the MoCA score. Conclusion: Serum LPS and HO-1 levels are closely related to cognitive impairment in patients with OSA and have potential clinical value in the diagnosis. Keywords: obstructive sleep apnoea, cognitive impairment, lipopolysaccharide, nuclear factor erythroid 2-related factor 2, haem oxygenase 1 Obstructive sleep apnoea (OSA) is a sleep-breathing disorder that can cause intermittent hypoxia, hypercapnia and disruption of sleep architecture. 1 Reduced cognitive function is a common disorder in patients with OSA, manifested by reduced attention and memory. 2 Cognitive impairment mainly includes perceptual impairment, memory impairment and thinking impairment. Patients often experience symptoms such as delayed sensation, memory loss or errors and delusions. 3 Obstructive sleep apnoea is an independent risk factor for cognitive impairment and it is important to identify OSA when assessing patients with such impairment. 4 Repeated courses of airway collapse and obstruction in patients with OSA induces recurrent apnoea and periodic arousal during sleep, leading to intermittent hypoxia and excessive daytime sleepiness and contributing to the occurrence and development of neuroinflammation and consequent neurocognitive impairments. 5 Nuclear factor erythroid 2-related factor 2 (Nrf2) is an important signalling pathway in the oxidative stress response, 6 and Nrf2 activation is important in promoting anti-inflammation. 7 High haem oxygenase 1 (HO-1) expression is closely associated with impaired cognitive function. 8 Kohman et al 9 demonstrated that intraperitoneal injection of lipopolysaccharide (LPS) caused activation of toll-like receptors in rats, resulting in increased expression of the inflammatory factors, interleukin (IL)-1β, IL-6 and tumour necrosis factor-alpha (TNF-α). In recent years, oxidative stress and inflammatory response and their interrelationship have become the main direction of research on the mechanism of cognitive impairment in patients with OSA. This study investigates the relationship between serum LPS, Nrf2 and HO-1 levels and cognitive impairment in patients with OSA. Comparisons are made between the groups with normal cognition and cognitive dysfunction to provide a reference value for clinical diagnosis or prediction of cognitive impairment in patients with OSA. A convenience sampling method was used to select patients with OSA and medical examiners at our hospital between January 2020 and December 2022 as the study population. The case group comprised 123 patients who underwent sleep monitoring and were diagnosed with OSA; the group included 75 men, and the overall mean age was 39.32 years. The control group comprised 100 healthy people who were examined at the health screening centre; the group included 56 men, and the overall mean age was 41.12 years. Age, sex, alcohol consumption, body mass index (BMI) and prevalence o -Abstract Truncated-

Dysfunction of Nrf 2-ARE Signaling Pathway : Potential Pathogenesis in the Development of Neurocognitive Impairment in Patients with Moderate to Severe Obstructive Sleep Apnea-Hypopnea Syndrome

Neurocognitive Impairment is Correlated with Oxidative Stress in Patients with Moderate-to-severe Obstructive Sleep Apnea Hypopnea Syndrome

Correlation Analysis of Serum Lipopolysaccharide, Nuclear Factor Erythroid 2-Related Factor 2 and Haem Oxygenase 1 Levels and Cognitive Impairment in Patients with Obstructive Sleep Apnoea

Altered Functional Connectivity of Temporoparietal Lobe in Obstructive Sleep Apnea: A Resting-State fNIRS Study

Neurocognitive impairment in Chinese patients with obstructive sleep apnoea hypopnoea syndrome.

Mitochondrial dysfunction is associated with cognitive impairment in adults with OSA without dementia

TDP43/HDAC6/Prdx1 Signaling Pathway Participated in the Cognitive Impairment of Obstructive Sleep Apnea Via Regulating Inflammation and Oxidative Stress

The study of the relationship between moderate to severe sleep obstructive apnea and cognitive impairment, anxiety, and depression

Evaluation of nocturnal apnea and airflow limitation as indicators for cognitive dysfunction in patients with chronic obstructive pulmonary disease/obstructive sleep apnea hypopnea syndrome overlap syndrome

Relationship Between Brain—derived Neurotrophic Factor and Cognitive Function of Obstructive Sleep Apnea/hypopnea Syndrome Patients

Aberrant Hippocampal Network Connectivity Is Associated With Neurocognitive Dysfunction in Patients With Moderate and Severe Obstructive Sleep Apnea

[Early Signs of Cognitive Impairment in Patients with Obstructive Sleep Apnea Hypopnea Syndrome: an Event-Related Potential Study].

Association between cyclic variation in the heart rate index and biomarkers of neurodegenerative diseases in obstructive sleep apnea syndrome: A pilot study

Altered amyloid-β and tau proteins in neural-derived plasma exosomes in obstructive sleep apnea

Resting-State fMRI Network Efficiency as a Mediator in the Relationship Between the Glymphatic System and Cognitive Function in Obstructive Sleep Apnea Hypopnea Syndrome: Insights from a DTI-ALPS Investigation

Widespread aberrant functional connectivity throughout the whole brain in obstructive sleep apnea

Altered resting-state hippocampal and caudate functional networks in patients with obstructive sleep apnea

Reduced regional homogeneity and neurocognitive impairment in patients with moderate-to-severe obstructive sleep apnea

Aberrant functional connectivity in patients with obstructive sleep apnea-hypopnea syndrome: a resting-state functional MRI study

Sleep Biomarkers, Health Comorbidities, and Neurocognition in Obstructive Sleep Apnea

Peripheral blood oxidative stress markers for obstructive sleep apnea—a meta-analysis